217 related articles for article (PubMed ID: 7855218)
21. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
Nevins ME; Arnolde SM
Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
[TBL] [Abstract][Full Text] [Related]
22. Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: effects of N-methyl-D-aspartate agonists and antagonists.
Itzhak Y
Neurosci Lett; 1989 Oct; 104(3):314-9. PubMed ID: 2573019
[TBL] [Abstract][Full Text] [Related]
23. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.
French ED; Ferkany J; Abreu M; Levenson S
Neuropharmacology; 1991 Oct; 30(10):1039-46. PubMed ID: 1836840
[TBL] [Abstract][Full Text] [Related]
24. Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice.
Liljequist S
Psychopharmacology (Berl); 1991; 104(1):17-21. PubMed ID: 1831907
[TBL] [Abstract][Full Text] [Related]
25. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy.
Löscher W; Rundfeldt C; Hönack D
Eur J Neurosci; 1993 Nov; 5(11):1545-50. PubMed ID: 7904524
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists.
Kantak KM; Edwards MA; O'Connor TP
Pharmacol Biochem Behav; 1998 Jan; 59(1):159-69. PubMed ID: 9443551
[TBL] [Abstract][Full Text] [Related]
27. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.
Marquis KL; Paquette NC; Gussio RP; Moreton JE
J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412
[TBL] [Abstract][Full Text] [Related]
28. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
Marrannes R; Willems R; De Prins E; Wauquier A
Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
[TBL] [Abstract][Full Text] [Related]
30. Modulators of N-methyl-D-aspartate protect against diazepam- or phenobarbital-resistant cocaine convulsions.
Witkin JM; Tortella FC
Life Sci; 1991; 48(11):PL51-6. PubMed ID: 1847729
[TBL] [Abstract][Full Text] [Related]
31. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
[TBL] [Abstract][Full Text] [Related]
32. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
[TBL] [Abstract][Full Text] [Related]
33. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
Witkin JM; Gasior M; Heifets B; Tortella FC
J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643
[TBL] [Abstract][Full Text] [Related]
34. The discriminative stimulus effects of N-methyl-D-aspartate glycine-site ligands in NMDA antagonist-trained rats.
Nicholson KL; Balster RL
Psychopharmacology (Berl); 2009 Apr; 203(2):441-51. PubMed ID: 19183964
[TBL] [Abstract][Full Text] [Related]
35. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.
Lu Y; France CP; Woods JH
J Pharmacol Exp Ther; 1992 Nov; 263(2):499-504. PubMed ID: 1432686
[TBL] [Abstract][Full Text] [Related]
36. Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine.
Baron SP; Woods JH
Psychopharmacology (Berl); 1995 Mar; 118(1):42-51. PubMed ID: 7597121
[TBL] [Abstract][Full Text] [Related]
37. Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?
Jackson A; Sanger DJ
Psychopharmacology (Berl); 1988; 96(1):87-92. PubMed ID: 2906445
[TBL] [Abstract][Full Text] [Related]
38. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
Koek W; Woods JH; Colpaert FC
J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142
[TBL] [Abstract][Full Text] [Related]
39. Phencyclidine and the midbrain dopamine system: electrophysiology and behavior.
French ED
Neurotoxicol Teratol; 1994; 16(4):355-62. PubMed ID: 7968939
[TBL] [Abstract][Full Text] [Related]
40. N-methyl-D-aspartate receptor antagonist activity and phencyclidine-like behavioral effects of the pentadecapeptide, [Ser1]histogranin.
Shukla VK; Lemaire S; Dumont M; Merali Z
Pharmacol Biochem Behav; 1995 Jan; 50(1):49-54. PubMed ID: 7700954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
